Luc Bergeron

Roy MP, Calon F, Simonyan D, Bergeron L

Risk of Neutropenia in Adults Treated with Piperacillin-Tazobactam or Cefazolin: A Retrospective Cohort Study

Can J Hosp Pharm, 75 (3), 2022.

Résumé | Liens:

Dussautl S, Bergeron L

Quelles sont nos options de traitement pour la prise en charge de l’endométrite ?

Pharmactuel, 55 (1), 2021.

| Liens:

Fortin E, Thirion DJG, Ouakki M, Garenc C, Lalancette C, Bergeron L, Moisan D, Villeneuve J, Longtin Y,

Role of high-risk antibiotic use in incidence of health-care-associated Clostridioides difficile infection in Quebec, Canada: a population-level ecological study

Lancet Microbe, 2 (5), 2021.

Résumé | Liens:

Dolcé L, Quach C, Thirion DJG, Bergeron L, Gonzales M, Papenburg J, Dionne M, Fortin A, Fortin E

Surveillance of antimicrobial use in Québec acute-care hospitals: A survey

JAMMI, 3 (1), 2018.

Résumé

Lemieux P, Grégoire JP, Thibeault R, Bergeron L

Higher risk of neutropenia associated with piperacillin-tazobactam compared with ticarcillin-clavulanate in children

Clin Infect Dis, 60 (2), 2015.

Résumé | Liens:

Bergeron L

Can we afford to lose more antimicrobial drugs?

Expert Rev Anti Infect Ther, 6 (1), 2008.

| Liens:

Weiss K, Bergeron L, Bernatchez H, Goyette M, Savoie M, Thirion D

Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004

Int J Antimicrob Agents, 30 (4), 2007.

Résumé | Liens:

Bergeron L, Boulé M, Perreault S

Serotonin toxicity associated with concomitant use of linezolid

Ann Pharmacother, 39 (5), 2005.

Résumé | Liens:

Bergeron L, Boucher FD

Possible red-man syndrome associated with systemic absorption of oral vancomycin in a child with normal renal function

Ann Pharmacother, 28 (5), 1994.

Résumé | Liens: